Also trades as: ESLAW (NASDAQ) · $vol 0M
ESLA NASDAQ
Estrella Immunopharma, Inc.
1W: -5.8%
1M: -37.0%
3M: -8.8%
YTD: -18.0%
1Y: +18.9%
3Y: -89.5%
$1.14
+0.02 (+1.79%)
Weekly Expected Move ±11.4%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-05-15
EPS
$-0.05
▲ Beat +40.5%
Revenue
—
EPS Beat Streak: 3 quarters
Next Earnings
2026-06-30
EPS Estimate
$-0.08
Range: $-0.08 - $-0.08
Estimate vs Actual
Earnings Surprise History
5/15
EPS Beats
0/15
Revenue Beats
33%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | quarter | 2026-06-30 | $-0.17 | $-0.08 | ▲ 0.09 | $— | $— |
| 2026-04-28 | quarter | 2026-03-31 | $-0.18 | $-0.08 | ▲ 0.10 | $— | $— |
| 2026-03-31 | annual | 2027-12-31 | $-0.39 | $-0.32 | ▲ 0.07 | $— | $— |
| 2026-03-30 | annual | 2027-12-31 | $-0.46 | $-0.39 | ▲ 0.07 | $— | $— |
| 2026-03-30 | annual | 2026-12-31 | $-0.41 | $-0.39 | ▲ 0.02 | $— | $— |
| 2026-03-30 | quarter | 2026-06-30 | $-0.12 | $-0.17 | ▼ 0.05 | $— | $— |
| 2026-03-30 | quarter | 2026-03-31 | $-0.13 | $-0.18 | ▼ 0.05 | $— | $— |
| 2026-03-20 | quarter | 2027-03-31 | $— | $-0.12 | ▼ 0.12 | $— | $— |
| 2026-03-20 | quarter | 2026-03-31 | $— | $-0.13 | ▼ 0.13 | $— | $— |
| 2026-03-20 | quarter | 2027-12-31 | $— | $-0.04 | ▼ 0.04 | $— | $23,728,200 |
| 2026-03-20 | quarter | 2026-12-31 | $— | $-0.12 | ▼ 0.12 | $— | $— |
| 2026-03-20 | quarter | 2025-12-31 | $— | $-0.18 | ▼ 0.18 | $— | $— |
| 2026-03-20 | quarter | 2028-03-31 | $— | $-0.03 | ▼ 0.03 | $— | $25,705,500 |
| 2026-03-19 | annual | 2028-12-31 | $— | $-0.23 | ▼ 0.23 | $— | $98,867,000 |
| 2026-03-19 | annual | 2026-12-31 | $— | $-0.41 | ▼ 0.41 | $— | $— |
Earnings Call Transcripts
No transcripts available.